COLEC11 and viral infectious disease: These data, collectively with those in Figs. 4 and 6 A, B, and C, indicate that CL-11 has the capacity to enhance SARS-CoV-2 infection of human respiratory epithelial cells and suggest that virus infection promotes CL-11 and complement deposition (Fig. 8).